Arrhythmia Disorders News

Healio | Cardiology Today compiled a list of some of the most important news in cardiology from 2023.

The subset of patients with high-risk pulmonary embolism who had hemodynamic collapse had an in-hospital mortality rate of 42%, according to a retrospective analysis of a large registry.

Healio and Cardiology Today have compiled a list of the most-read news in cardiology in December 2023.

Catheter ablation for atrial fibrillation was associated with lower incidence of hospitalization for worsening HF vs. drug therapy in patients with HF with preserved ejection fraction, researchers reported.

A novel deep learning algorithm applied to a single preoperative ECG improved risk prediction for death after cardiac surgery and other inpatient procedures for a large cohort, researchers reported.

PHILADELPHIA — In the EMPA-ICD trial, patients with type 2 diabetes and an implantable cardioverter defibrillator had fewer ventricular arrhythmias at 24 weeks when assigned empagliflozin compared with placebo.

Vigorous physical activity of at least 20 minutes per week, shorter than that specified in guideline recommendations, was associated with reduced risk for cardiac arrest, according to findings published in EP Europace.

PHILADELPHIA — In people with congenital long QT syndrome, vigorous exercise did not raise risk for death or ventricular arrhythmias compared with nonvigorous exercise, according to the results of the LIVE-LQTS study.

In a proof-of-concept phase 2 trial, a novel SK ion channel inhibitor successfully converted atrial fibrillation to sinus rhythm compared with placebo.

Medtronic announced the FDA approved its pulsed field ablation system for treatment of both paroxysmal and persistent atrial fibrillation via pulmonary vein isolation.